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Circadian rhythms offer temporal control of antici-
patory physiologic adaptations in animals. In the
mammalian cardiovascular system, the importance
of these rhythms is underscored by increased car-
diovascular disease in shift workers, findings reca-
pitulated in experimental animal models. However,
a nodal regulator that allows integration of central
and peripheral information and coordinates cardiac
rhythmic output has been elusive. Here, we show
that kruppel-like factor 15 (KLF15) governs a
biphasic transcriptomic oscillation in the heart with
a maximum ATP production phase and a remodeling
and repair phase corresponding to the active and
resting phase of a rodent. Depletion of KLF15 in
cardiomyocytes leads to a disorganized oscillatory
behavior without phasic partition despite an intact
core clock. Thus, KLF15 is a nodal connection be-
tween the clock and meaningful rhythmicity in the
heart.INTRODUCTION
A large number of physiological processes in animals exhibit
circadian rhythmicity. These oscillations are under the con-
trol of the molecular clock, an auto-regulatory transcriptional
network that exists in all cells. It is estimated that 50% of
the genome has the potential to oscillate, although only 3%–
10% do in any given tissue context (Akhtar et al., 2002; Panda
et al., 2002; Storch et al., 2002; Ueda et al., 2002; Zhang et al.,
2014). Further, even genes oscillating in more than one tissue
often vary in phases among different organs (Panda et al.,
2002; Zhang et al., 2014). Thus, the optimum physiological
benefit at an organ level is achieved by a coordinated gene
expression integrating signals from the central clock, local
clock, and environmental cues (zeitgebers). However, our un-
derstanding of how a universally oscillating clock achieves this
sophisticated regulation of gene expression in each peripheral
organ remains limited.2368 Cell Reports 13, 2368–2375, December 22, 2015 ª2015 The AuClinical and experimental evidence supports a critical role for
circadian rhythms and the molecular clock in cardiovascular
physiology and pathobiology. A number of physiologic parame-
ters such as heart rate and blood pressure have a 24-hr rhythm
(Millar-Craig et al., 1978). There is a clear predilection for major
cardiac events (e.g., heart attack or sudden death) to occur at
a certain time of the day, specifically the early morning period
(Cohen et al., 1997; Muller et al., 1985). Night shift workers are
at increased risk for cardiovascular and metabolic diseases
(Knutsson et al., 1986; Viitasalo et al., 2012). Finally, animals
bearing a disruption in the molecular clock components are
predisposed to cardiovascular disease (e.g., coronary artery
disease and cardiomyopathy) along with a number of other
problems such as metabolic syndrome and accelerated aging
(Durgan et al., 2011; Lefta et al., 2012).
The heart must anticipate and adapt to an unrelenting energy
demand over a wide spectrum of physiologic states throughout a
24-hr day. Recent studies have identified the transcription factor
KLF15 as a circadian metabolic regulator of nutrient flux in the
context of day/night cycles, fasting, and exercise adaptation
(Gray et al., 2007; Haldar et al., 2012; Jeyaraj et al., 2012b; Pros-
docimo et al., 2014). We sought to investigate the role of KLF15
in the diurnal rhythms in the heart.
RESULTS
KLF15 Is a Nodal Regulator of Cardiac Diurnal Gene
Expression
To assess the role of KLF15 in cardiac circadian regulation,
we generated cardiomyocyte-specific KLF15 knockout mice
(cK15) by crossing the a-MHC cre mice (cre) with floxed Klf15
mice (Figure S1A). Although phenotypically indistinguishable at
baseline, the cK15 mice demonstrated decompensated cardiac
function following pressure overload stress (Figures S1B–S1F),
similar to what has been observed in the systemic knockout
(Fisch et al., 2007). For cardiac diurnal transcriptomic studies,
unstressed cK15 and cre mice were kept in a 12-hr light-dark cy-
cle with ad lib food access, and hearts were sampled every 4 hr
during a continuous 24-hr period. Analysis of the diurnal cardiac
transcriptome was performed by RNA sequencing analysis
(RNaseq) followed by JTK_CYCLE (Hughes et al., 2010) to pre-
dict genes that display a 24-hr rhythmicity.thors
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Figure 1. The Circadian Transcriptome Is Altered by KLF15 Deficiency in the Heart
(A and B) The number of all oscillating transcripts identified by RNaseq using JTK_CYCLE, p < 0.05. (A) Venn diagram. (B) Summary.
(C–E) Expression heat map organized by phase of genes oscillating only in cre (C), common in both cre and cK15, (D), and only in cK15 (E), respectively.We identified 1,335 (1,003 + 332) oscillating genes in the con-
trol mice (cre) using a cutoff of p < 0.05 (Figures 1A and 1B;
also, see Table S1 for all differentially expressed genes). This is
consistent with the previous transcriptomic studies in different
tissues/organs that 3%–10%of the transcriptome oscillate (Akh-
tar et al., 2002; Panda et al., 2002; Storch et al., 2002; Ueda et al.,
2002). In these 1,335 genes, 1,003 (75%, 1,003/1,335) oscillates
in a KLF15-dependent fashion, and 332 (25%, 332/1,335) genes
are rhythmic in both genotypes (Figures 1A–1D). In addition,
there are a surprisingly large number of genes (473) that oscillate
exclusively in cK15 (Figure 1E). The mean expression of either
the 1,003 genes or the 473 genes is not significantly different be-
tween cre and cK15, although there is a trend toward reduced
expression in cK15 in the 1,003 genes (Figure S1G). This result
suggested a significant alteration in the diurnal expression gating
in the KLF15-deficient heart.
KLF15 Regulates a Biphasic Temporal and Functional
Clustering of Cardiac Genes
To deduce the clock control on cardiac physiology, we plotted
the phase distribution of oscillating genes. Interestingly, in cre
controls, the phase lag shows a bimodal distribution with one
peak during the day (ZT0–ZT6) and the other during the night
(ZT14–ZT20) (Figure 2A). We confirmed this bimodal distribution
in a previously published independent dataset from the heart
(Tsimakouridze et al., 2012) (Figure S2A). A similar distribution
was not seen in datasets from several other tissues, including
the liver (Figure S2B) (Hoogerwerf et al., 2008; Masri et al.,
2014; Rudic et al., 2005). Remarkably, the biphasic distributionCell Repof phase lag observed in cre is abolished in cK15 mice despite
still having a significant total number of oscillating genes
(805, 332 + 473) (Figure 2B), indicating that the biphasic phase
distribution is dependent on the presence of KLF15 in the
cardiomyocytes.
We hypothesized that the genes clustered under each of these
two peaksmight be informative of the specific aspects of cardiac
physiology governed by the peripheral clock. In cre, Kyoto Ency-
clopedia of Genes and Genomes (KEGG) pathway analysis of
the oscillating genes with peak expression during the night
(ZT14–ZT20) showed enrichment for the core clock machinery
(circadian rhythm) and key catabolic pathways, including fatty
acid metabolism and several amino acid degradation pathways
(lysine, branch chain amino acids, tryptophan, and tyrosine) (Fig-
ure 2C, top). This is consistent with the peak energy demand and
food intake during active phase for nocturnal rodents. On the
other hand, oscillating genes with peak expression during the
day (ZT0–ZT6) showed a distinct enrichment for focal adhesion,
extracellular matrix receptor interaction, and regulation of actin
cytoskeleton (Figure 2C, bottom). Several cancer-related path-
ways also have peak expression at daytime, consistent with pre-
viously proposed resting phase DNA repair in neurons (Kang
et al., 2009). This suggests a function priority shift of the heart
from providing energy to sustain activity phase to a remodeling
and repair phase.
Importantly, the known core clock genes oscillate in both cre
and cK15, including Arntl (BMAL1) and Per2 (Figures 1D and
S2C). The undisturbed core clock machinery confirmed our pre-
vious observation that Klf15 functions downstream of the clockorts 13, 2368–2375, December 22, 2015 ª2015 The Authors 2369
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Figure 2. KLF15 Is Required for the Biphasic Transcriptomic Oscillation in the Heart
(A andB) Histogramof phase distribution for all oscillating genes in cre (A) and in cK15 (B); yellow shows the peak during daytime (ZT0-6), and blue shows the peak
during nighttime (ZT14-20).
(C) KEGG pathway analysis of all oscillating genes in cre with phase lag between ZT14-20 (upper) and ZT0-6 (lower).
(D) Histogram of phase distribution for KLF15 dependent oscillating genes.
(E) KEGG pathway analysis of KLF15-dependent oscillating genes with phase lag between ZT14-20.machinery (Jeyaraj et al., 2012a). Furthermore, known nuclear
receptors PPARs that may contribute to diurnal rhythmic gene
expression are not affected (Figure S2D). The common oscil-
lating genes are also enriched for ABC transporter, glutathione
metabolism, and drug metabolism during the night (ZT14–
ZT20) and focal adhesion and ECM receptor signaling during
the day (ZT0–ZT6) (Figures S2E and S2F), suggesting these are
KLF15-independent oscillatory processes. Interestingly, a small
but discernible phase advance in cK15 is observed in these
332 genes that oscillate in both genotypes (Figure S2G).
KLF15 Directly Regulates Genes for Catabolism in the
Active Phase
Given the large number of genes that lost rhythmic expression
in cK15, we then focused on these 1,003 genes (Figure 1C).
Similar to the oscillatory transcriptome in cre, most genes have
a peak expression clustered either at the night-day transition
or the day-night transition (Figure 2D), further confirming that
the biphasic phase lag is driven by KLF15. KEGG analysis of2370 Cell Reports 13, 2368–2375, December 22, 2015 ª2015 The Authe 407 KLF15-dependent oscillatory genes with peak expres-
sion between ZT14-ZT20 showed enrichment for lysine degra-
dation, fatty acid metabolism, and branch chain amino acid
degradation (Figure 2E), a subset of enriched pathways in the
control mice, all of which are critical for energy conversion
from food source. This indicates a central role of KLF15 in
optimizing the ATP production during the night when the energy
demand is at peak in the heart. We confirmed the expression of
several key components of these metabolic pathways by qRT-
PCR (Figure 3A). ALDH2 (mitochondrial aldehyde dehydroge-
nase 2) and DBT (dihydrolipoamide branched chain transacylase
E2) were selected for further verification and showed reduced
protein expression in the heart of the cK15 mice (Figures 3B
and 3C). In vitro, NRVMs (neonatal rat ventricular myocytes)
overexpressing KLF15 showed induced expression of both
RNA and protein of ALDH2 and DBT, consistent with a cell
autonomous effect (Figures 3D–3G). Furthermore, chromatin
immunoprecipitation confirmed the enrichment of KLF15 on
Aldh2 and Dbt promoter, indicating a direct transcriptionalthors
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Figure 3. KLF15 Directly Regulates Multiple Target Genes in the Fatty Acid and Amino Acid Metabolic Pathways
(A) Circadian qRT-PCR using heart samples collected every 4 hr during a 24-hr period, n = 4 for each time point. Values aremean ±SEM. Expression is normalized
to Ppib. Dbt, *-time, ****-genotype; Ivd, ****-genotype; Aox1, ***time, ****-genotype; Aldh2, **-time, ****-genotype, two-way ANOVA, *p < 0.05, **p < 0.01,
***p < 0.001, ****p < 0.0001.
(B and C) Immunoblot showing decreased ALDH2 and DBT protein expression in cK15; GAPDH is used as loading control.
(D and E) qRT-PCR using NRVM infected with adenovirus carrying empty vector () or Klf15 cDNA (+), n = 3. Values are mean ± SEM. Expression is normalized to
Ppib. *p < 0.0001.
(F and G) Immunoblot of NRVM overexpressing KLF15 (Ad-Klf15) versus empty vector (Ad-Ev). Tubulin is used as loading control.
(H and I) NRVM is infected with adenovirus carrying FLAG-tagged mouse Klf15 cDNA. Recruitment of KLF15 on the Aldh2 and Dbt promoter is confirmed using
chromatin immunoprecipitation with anti-FLAG antibody followed by qPCR. Result is normalized to IgG. n = 5. Values are mean ± SEM, p = 0.05 (Aldh2),
p < 0.0001(Dbt). Primers can be found in Table S3.regulation (Figures 3H and 3I). KLF15 likely regulates multiple
targets directly in these catabolic pathways enriched during
the active phase, thereby enabling a coordinated effort for ATP
production. This metabolic signature is consistent with previous
microarray studies on the liver and the skeletal muscle of the sys-
temic KLF15 knockout mice (Table S2).
There are 342 KLF15-dependent oscillatory genes with peak
expression during the early daytime (ZT0–ZT6). The top three
pathways are MAPK signaling, regulation of actin cytoskeleton,
and small cell lung cancer, also representing a significant subset
of that of control mice. However, KEGG pathway analysis with a
cutoff of q < 0.05 after Benjamini correction did not reach statis-
tical significance. It is likely that KLF15 is also involved in the
regulation of cellular signaling pathways for cardiac remodeling
and repair.
KLF15 Is Required for REV-ERBa and NCOR-Dependent
Repression of Gene Oscillation
Most surprisingly, we identified 473 genes that gain oscillatory
behavior in the absence of KLF15 (Figure 1E). To further delin-
eate the possible mechanisms that may account for this gain in
oscillation, we then performed an unbiased, de novo motif anal-Cell Repysis using MEME (Multiple EM for Motif Elicitation) (Bailey et al.,
2009) on the promoter of the 473 genes that gained oscillation
to determine what motifs might be enriched. The top 15 motifs
were matched to database of known transcription factors. Six
motifs yielded cognate sites for transcription factor, and two of
them pointed to nuclear receptors (Figure 4A). Indeed, we found
cAMP-sensitive nuclear receptor, Nr4a3 (NOR1), among genes
oscillating only in cK15. NR4A subgroup includes three mem-
bers; Nr4a1 (NUR77) and Nr4a3 have significant functional
overlap, and both showed de novo diurnal oscillation in cK15,
with peak expression at ZT10 (Figure 4B). Nr4a2 (Nurr1) is
also cAMP sensitive; however, it remained non-oscillatory (Fig-
ure S3A), suggesting cAMP is unlikely the direct reason for
Nr4a1 or Nr4a3 to gain oscillation. Transient knockdown of
Klf15 in NRVM resulted in increased expression of both Nr4a3
and Nr4a1 mRNA and protein, suggesting that the gain of
expression and oscillation observed in the cK15 heart is directly
related to the loss of KLF15 (Figures 4C and 4D). In addition,
overexpression of Nr4a3 in NRVM leads to upregulation of
several targets identified by RNASeq (Figures 4E and 4F), further
supporting that these nuclear receptors at least account for a
subset of the genes that gains oscillation in the cK15 heart.orts 13, 2368–2375, December 22, 2015 ª2015 The Authors 2371
Because REV-ERBa (Nr1d1) is a circadian repressor with a
peak expression time that coincides with that of KLF15, we
asked whether REV-ERBa is critical for dampening the expres-
sion of Nr4a1 and Nr4a3 and whether this inhibition requires
KLF15. There is no significant difference in the expression of
Nr1d1 or Ncor (encodes its co-repressor NCOR) between
cK15 and cre (Figure S3B). However, the binding of REV-ERBa
and NCOR on the promoter ofNr4a1 andNr4a3 is strongly atten-
uated in the absence of KLF15 (Figure 4G). Also, ChIP-seq of
REV- ERBa in the heart of cK15 mice showed a significantly
reduced number of binding sites compared to the floxed mice,
including those associated with key regulatory elements on the
promoter of Nr4a1 and Nr4a3, while the binding on the Bmal1
promoter is unchanged as predicted (Figures S4A–S4D). To
further substantiate our hypothesis, we tested whether loss of
KLF15 leads to increased responsiveness of Nr4a1 and Nr4a3
to other cellular signals. We chose to test glucocorticoid (GC),
as it has a well-characterized diurnal rhythmicity reaching peak
serum level between ZT9-12, during which time the expression
of Nr4a1 and Nr4a3 also peaked. As predicted, dexamethasone
administration was only able to induce Nr4a1 and Nr4a3 in
the absence of KLF15 (Figures 4H and 4I). As GC induces
KLF15, this complex relationship exemplifies a recently identi-
fied mode of GC action, namely, incoherent feed forward
loop, (Sasse et al., 2013) and allows integration of complex
input signals.
In contrast to the genes that oscillate in the WT hearts or
those that oscillate in a KLF15-dependent fashion, the phase
lag of the genes that gain oscillation in cK15 does not reveal
a distinctive clustering around dawn or dusk (Figure 4J). Addi-
tionally, KEGG pathway or Gene Ontology (GO) analysis also
did not reveal any significant clustering of annotation. This
lack of both an organized temporal distribution and coordinated
functional pathway suggests that these genes were inhibited
from oscillation by KLF15 under physiological condition to
ensure efficiency toward the desired function of the heart.
Conversely, KLF15 deficiency may lead to futile or even harmful
fluctuation in the system.
DISCUSSION
The circadian clock is conserved through evolution and is crit-
ical for organismal homeostasis, yet it is highly adaptive, with
different output in different tissue and cell types. It is poorly un-
derstood how this is achieved. Our findings demonstrate that
Kruppel-like factor, KLF15, establishes the diurnal landscape
of gene expression in the heart. It directs 75% of the oscillatory
transcriptome in a biphasic fashion and prevents genes poten-
tially oscillates in other tissue context from creating noise, thus
allowing a temporal and functional specific partition in the heart
(Figure 4K).
Our work adds important insights to the previous understand-
ing of circadian gene expression in the heart. Among the two
other published dataset, one is the pioneer work by Storch
et al. (2002), which identified a single cluster around CT4 (circa-
dian time). The other one is the recently published compre-
hensive study by Zhang et al. (2014), which identified another
single cluster around CT16. As both studies sampled during2372 Cell Reports 13, 2368–2375, December 22, 2015 ª2015 The Au‘‘free-run,’’ it is unlikely the testing condition can account for
the difference. However, a closer examination of the dataset re-
veals that the earlier versions of oligoarray represent only 30%
of the mouse genome, which may lead to decreased detection.
The more recent study used RNaseq, but sampled more
sparsely (every 6 hr) and had more extensive pooling (six sam-
ples per lane) features that may reduce sensitivity. As each of
these datasets represents a different subset of our result, which
is also replicated using a completely independent dataset ob-
tained on a different platform (oligoarray) (Tsimakouridze et al.,
2012), we believe the results provided here offer an improved
depiction.
Most work in circadian biology to date has focused on mech-
anisms promoting oscillation. However, mechanisms that sup-
press oscillation are just as important to orchestrate a specific
gene expression landscape. Our unexpected observation that
a significant number of genes gain oscillatory behavior in the
absence of KLF15 offered a novel mechanism of diurnal gene
regulation. We show that KLF15 is required for binding of circa-
dian repressors, REV-ERBa and NCOR to maintain quiescent
expression of a subset of genes in the heart, and lack of KLF15
leads to aberrant oscillation of gene expression responding to
cellular signals including the GC. The binding of REV-ERBa on
the Arntl promoter is not KLF15 dependent. In fact, the observa-
tion that core clock genes, such as Arntl, did not change ex-
pression pattern, despite being a REV-ERBa target further
strengthened our notion that the core clock gene defines
‘‘time’’ and KLF15 defines ‘‘locale’’; together, they achieve a
perfectly orchestrated ‘‘temporal-spatial’’ expression.
It was recently noted that changes in metabolic state may
drive rhythmic gene expression in metabolic organs through
the rhythmic ligand availability of nuclear receptors such as
PPAR (Eckel-Mahan et al., 2013). We did not detect a rhythmic
expression of PPARa, b, or g, among which PPARa has long
been known for its critical role in cardiac energy metabolism.
More importantly, we have recently reported that the ligand-
induced PPARa activity in the heart is dependent on the pres-
ence of KLF15 (Prosdocimo et al., 2015); thus, it is unlikely that
the fluctuation of ligand or metabolic states will account for the
gain of oscillatory genes in cK15.
The unique biphasic physiology of the heart allows the heart
time to repair for the damage as a direct result of cellular meta-
bolism each day. Multiple lines of evidence have suggested that
the heart is more vulnerable to hypertrophy yet receives greater
cardiac remodeling benefit from angiotensin-converting enzyme
inhibitors during the resting phase in both animal and human
studies (Durgan et al., 2011; Flack and Nasser, 2011; Hermida
and Ayala, 2009; Hermida et al., 2010; Martino et al., 2011;
Sleight et al., 2001). The rationale behind this was not under-
stood. We discovered that the transcriptome of the heart is pro-
grammed to perform cardiac remodeling and repair during the
resting phase, and KLF15 deficiency, as seen in multiple chronic
cardiovascular disorders, such as heart failure and aortic aneu-
rysm, leads to loss of this critical window for ‘‘routine mainte-
nance.’’ Importantly, we have identified a list of potential targets
(peak expression at ZT0-6), which opens the window for chrono-
therapeutic options for the prevention and treatment of cardio-
vascular disease.thors
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EXPERIMENTAL PROCEDURES
Detailed methods are provided in the Supplemental Experimental Procedures.
See Table S3 for primers.
Animals
Male mice on C57BL/6J background at 11 to 12 weeks of age were housed in
12-hr light/12-hr dark conditions. Heart samples (n = 4 mice) were collected
every 4 hr. All animal experiments were in accordance with guidelines of the
Case Western Reserve University Animal Care and Use Committee.
Whole Transcriptome Sequencing
RNA was isolated from apex of the heart using Trizol (Life Technologies) fol-
lowed with miRNeasy Kit (QIAGEN). Ribo-depleted RNA was used to generate
library using the Illumina TruSeq Stranded Total RNA kit; 100-bp paired-end
sequencing was performed on pooled libraries in groups of three using an Illu-
mina Hiseq 2500 instrument at IIGB Genomics Core at the University of Cali-
fornia, Riverside.
RNaseq Data Analysis
Illumina reads were mapped to mouse genome release mm10 using GSNAP
program. Reads mapped to single location in mm10 genome were retained
for further analysis. The raw read counts for each gene in mm10 RefSeq anno-
tation were generated using HTSeq program (Anders et al., 2014). The expres-
sion levels of genes were presented as FPKM (fragments per kilo bases of
exon per million of mapped reads) values.
Time Series Analysis for Circadian Rhythmicity
RNA cycling was assessed by JTK_cycle (Hughes et al., 2010) with a period of
24 hr and a cutoff of p% 0.05.
ACCESSION NUMBERS
The data discussed in this manuscript have been deposited in NCBI GEO and
areaccessible under accessionnumberGEO:GSE63243andGEO:GSE73741.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, and three tables and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2015.11.038.Figure 4. De-repression of REV-ERBa on Nuclear Receptors Nor1 (Nr
Oscillation in cK15
(A) Motif alignment of nuclear receptor responsive element (NRRE) and two prom
(B) Circadian qRT-PCR, using heart samples collected every 4 hr during a 24-
normalized to Ppib. Nr4a3, *-time, ***-genotype, **-interaction; Nr4a1, ****-time,
0.001, ****p < 0.0001.
(C) qRT-PCR of NRVM knockdown with short hairpin RNA against scrambled targ
are mean ± SEM. Expression is normalized to Ppib.
(D) Immunoblot of NRVM knockdown with sh-sc or sh-Klf15. Tubulin is used as l
(E) qRT-PCR of the indicated genes in NRVM transfected with control vector or a p
0.013 (Slc7a8). Values are mean ± SEM. Expression is normalized to Ppib.
(F) Circadian qRT-PCR, using heart samples collected every 4 hr during a 24-h
normalized to Ppib. Plin2, ****-genotype; Slc1a5, ***-time, ****-genotype; Slc7a8
****p < 0.0001.
(G) Chromatin immunoprecipitation in NRVM knockdown with short hairpin RNA
and NCOR is shown on the Nr4a1 and Nr4a3 promoter using chromatin immunop
values are mean ± SEM, p = 0.02 (Nr4a1, REV-ERBa), p = 0.04(Nr4a1, NCOR), p
Table S3.
(H) qRT-PCR of NRVM knockdown with short hairpin RNA against scrambled ta
versus sh-K15, p = 0.0002 (Nr4a1), p < 0.001 (Nr4a3); #-sh-K15 versus sh-K15+De
normalized to Ppib.
(I) Schematic diagram of KLF15 recruiting REV-ERBa and NCOR to repress targ
(J) Histogram of phase distribution for genes only oscillated in cK15.
(K) Schematic diagram of KLF15 in the circadian gene expression in the heart.
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